Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), bought 10,000 shares at $18.00 ($180K) on 2014-07-23, disclosed to the SEC on 2014-07-23.
Open-market purchase of $180k SAGE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |